【24h】

Regenerative technologies in the treatment of knee osteoarthritis

机译:膝关节骨关节炎的再生技术

获取原文

摘要

Knee osteoarthritis (OA) causes substantial pain, physical dysfunction and impaired quality of life. There is no cure for knee OA, and for some people, the disease may involve progressive symptomatic and structural deterioration over time. Platelet-rich plasma (PRP) is a therapeutic agent that aims to address underlying biological processes responsible for OA pathogenesis. Thirty four women with 2nd or 3rd Kellgren-radiologic stage OA had been divided into 3 groups. All ones were treated by hyaluronic acid intra-articular injection. Fifteen patients (1st group) hadn't got any additional treatment. AS was carried out for 6 peoples (2nd group). For 13 patients (3rd group) PRP intra-articular injections were used in common with medical AS. The growth of cartilage in the region of the upper pole of the patella was found in the 1st group after 3 months of treatment: mean values 1.84 vs. 2.39, p = 0.015. Positive dynamic was also detected at 3 and 6 months in the second (the mean values were 2.08 vs. 2.45 and 2.42, p=0.049) and third groups of patients (2.3 vs. 2.8 and 2.35, p=0.02). The cartilage thickness in the medial condyle of the tibia had increased at 3 and 6 months in the 2nd (the mean values were 1.61 vs. 2.11 and 1.98, p = 0.001) and 3rd group (1.66 vs. 2.01 and 1.89, p = 0.019). A change of the cartilage thickness in the lateral condyle of the tibia was not statistically significant in the all groups of patients. The pain level, stiffness, restriction decreased according to the questionnaire (WOMAC, Leken index) in all groups of patients. The clinical effectiveness of intra-articularly hyaluronic acid therapy and surgical methods of OA-treatment (medical AS) have been confirmed by ultrasound visualization and questionnaires.
机译:膝骨关节炎(OA)会导致严重的疼痛,身体机能障碍和生活质量受损。无法治愈膝盖骨关节炎,对于某些人来说,这种疾病可能会随着时间的推移而逐渐发展为症状性和结构性恶化。富血小板血浆(PRP)是一种治疗药物,旨在解决导致OA发病机理的潜在生物学过程。 34例患有第二期或第三期Kellgren放射线检查的OA妇女被分为3组。所有患者均接受透明质酸关节内注射治疗。 15名患者(第一组)未接受任何其他治疗。 AS进行了6人(第二组)。对于13例患者(第三组),PRP关节腔内注射与医学AS共同使用。在治疗3个月后的第一组中发现found骨上极区域的软骨生长:平均值1.84对2.39,p = 0.015。在第二个月(平均值分别为2.08 vs. 2.45和2.42,p = 0.049)和第三组患者(分别为2.3 vs. 2.8和2.35,p = 0.02)的第3和6个月也检测到阳性动态。在第二组中,胫骨内侧the的软骨厚度在第3和6个月增加(平均值分别为1.61和2.11和1.98,p = 0.001)和第3组(分别为1.66和2.01和1.89,p = 0.019) )。在所有患者组中,胫骨外侧con的软骨厚度变化均无统计学意义。根据问卷调查(WOMAC,Leken指数),所有患者组的疼痛程度,僵硬,约束减少。超声可视化和问卷调查证实了关节内透明质酸疗法的临床有效性和OA治疗的手术方法(医学AS)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号